Eurobio Scientific Société anonyme (EPA:ALERS)

France flag France · Delayed Price · Currency is EUR
23.00
-0.90 (-3.77%)
Apr 28, 2026, 3:16 PM CET
-5.56%
Market Cap 231.57M
Revenue (ttm) 169.00M
Net Income (ttm) 4.90M
Shares Out 10.07M
EPS (ttm) n/a
PE Ratio 47.26
Forward PE 20.35
Dividend n/a
Ex-Dividend Date n/a
Volume 172
Average Volume 524
Open 23.00
Previous Close 23.90
Day's Range 23.00 - 24.10
52-Week Range 20.40 - 25.95
Beta 0.68
RSI 56.70
Earnings Date Apr 10, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 320
Stock Exchange Euronext Paris
Ticker Symbol ALERS
Full Company Profile

Financial Performance

In 2025, EPA:ALERS's revenue was 169.00 million, an increase of 9.07% compared to the previous year's 154.95 million. Earnings were 4.90 million, an increase of 22.56%.

Financial Statements

News

There is no news available yet.